ACTRN12608000236392招募中2 期
Study of bosentan in the management of angina in patients with Coronary Slow Flow phenomenon
Cenral Northern Adelaide Health Service - The Queen Elizabeth Hospital0 个研究点目标入组 26 人开始时间: 2008年5月8日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Coronary Slow Flow Phenomenon. Angina frquency>3 episodes/week
排除标准
- •Pulmonary hypertension,liver disease.Cyclosporin,glibenclamide,ketoconazole
研究者
相似试验
已完成
不适用
Treatment of Thromboangiitis Obliterans (Buerguer's Disease) With BosentanThromboangiitis ObliteransNCT01447550Hospital Universitario Getafe12
进行中（未招募）
不适用
Safety and efficacy study of bosentan in progressive pulmonary sarcoidosis - BOPSACProgressive pulmonary sarcoidosisMedDRA version: 9.1Level: PTClassification code 10037430Term: Pulmonary sarcoidosisEUCTR2007-005117-18-ATMedical University of Vienna, Department of Clinical Pharmacology
已完成
4 期
The Clinical And Subclinical Effects on Arterial Stiffness of Bosentan in Patients With Systemic SclerosisScleroderma, SystemicNCT02480335University Medical Center Groningen20
招募中
不适用
Clinical and cardiac imaging in bosentan treatment for pulmonary arterial hypertensioDiseases of the circulatory systemKCT0001530The Catholic University of Korea, Seoul St. Mary's Hospital21
进行中（未招募）
不适用
The role of Bosentan in fontan patients: improvement of aerobic capacity - bosentan in fontan patientsTo study whether bosentan (endothelin receptor inhibitor) improves aerobic capacity (VO2max) and exercise performance in adult patients with a Fontan operation.MedDRA version: 9.1Level: LLTClassification code 10064911Term: Pulmonary arterial hypertensionEUCTR2008-004533-21-NLICI50